Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-08-22 to 2025-12-21
Current total value of award: $4292641
Description: DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH PHASE III INTEGRATING ISOAGGLUTININ REDUCTION FOR A UNIVERSAL DRIED PLASMA PRODUCT FOR BATTLEFIELD AND FIRST RESPONDER USE